Access Biotechnology and returning investor Eli Lilly were among the participants in a series B round for the RNA-based drug developer.

Acorn Bioventures has led a series B round for the cancer-focused biopharmaceutical spinout of CU Boulder.

Sumitomo Corporation of Americas and Ingka Investments helped the on-demand commercial vehicle provider close its series A round.

AbbVie has bought an exclusive option to acquire Mitokinin once the UCSF spinout completes IND-enabling studies for its Parkinson’s treatment.

Zhongnan Capital and SAIC's FOF Hengxu Capital contributed to a $15.5m round that will support technology development and hiring.

Nationwide Ventures co-led a $15m series B round for the health data platform developer that included Aflac Corporate Ventures and Epsilon Health Investors.

NetEase and Sony Music Entertainment contributed to a round that boosted the livestreaming platform developer's overall funding to $22m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

WeGift has boosted its series A-plus round to $12m with a $4m investment by Commerzbank's venture capital arm.

LabCorp Venture Fund, Bristol Myers Squibb and Takeda Ventures contributed to $7m in equity funding and a $6m convertible note for the cancer drug developer.